DarioHealth Corp.(DRIO)

$7.04—

Chart

DarioHealth Corp.(DRIO)

NASDAQ

$7.04—

Chart Studio

DRIO(DRIO)

DRIO

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.74

Aug 11, 2026 · Reports before open

Revenue Estimate

$6M

FY2030E EPS$0.29

Analyst Sentiment

Wall St. Consensus

Buy

9 analysts·Limited coverage

Score

8 Buy (89%)1 Hold (11%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

889%

Hold

111%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$7.50

+9.0%

Consensus

$14.00

+103.5%

Bull

$16.00

+132.6%

12-Month Target Range9 analysts

$7.50$14.00$16.00

Current $6.88Consensus

Current Price

$6.88

Upside to Consensus

$7.12

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+46.13%

EPS—

FY2028

Rev+39.36%

EPS—

FY2029

Rev+26.49%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$26M	$38M	$53M	$67M	$85M
Low	$25M	$37M	$51M	$65M	$81M
High	$27M	$39M	$55M	$69M	$87M
EBITDA Avg	$-26M	$-38M	$-53M	$-67M	$-85M
Low	$-27M	$-39M	$-55M	$-69M	$-87M
High	$-25M	$-37M	$-51M	$-65M	$-81M
EBIT Avg	$-26M	$-38M	$-53M	$-67M	$-85M
Low	$-27M	$-39M	$-55M	$-69M	$-87M
High	$-25M	$-37M	$-51M	$-65M	$-81M
Net Income Avg	$-183M	$-96M	$-51M	$-20M	$15M
Low	$-190M	$-100M	$-75M	$-21M	$14M
High	$-175M	$-92M	$-27M	$-19M	$15M
EPS Avg	$-3.71	$-1.94	$-1.03	$-0.40	$0.29
Low	$-3.83	$-2.01	$-1.52	$-0.41	$0.28
High	$-3.53	$-1.85	$-0.55	$-0.38	$0.30
Analysts (Rev / EPS)	3 / 2	2 / 2	2 / 2	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$7M	$8M	$9M	$9M	$10M	$12M	$13M	$12M
Low	$7M	$8M	$9M	$9M	$10M	$12M	$13M	$12M
High	$7M	$8M	$9M	$10M	$10M	$12M	$13M	$12M
EBITDA Avg	$-7M	$-8M	$-9M	$-9M	$-10M	$-12M	$-13M	$-12M
Low	$-7M	$-8M	$-9M	$-10M	$-10M	$-12M	$-13M	$-12M
High	$-7M	$-8M	$-9M	$-9M	$-10M	$-12M	$-13M	$-12M
EBIT Avg	$-7M	$-8M	$-9M	$-9M	$-10M	$-12M	$-13M	$-12M
Low	$-7M	$-8M	$-9M	$-10M	$-10M	$-12M	$-13M	$-12M
High	$-7M	$-8M	$-9M	$-9M	$-10M	$-12M	$-13M	$-12M
Net Income Avg	$-54M	$-52M	$-39M	$-35M	$-31M	$-20M	$-17M	$-22M
Low	$-55M	$-53M	$-40M	$-36M	$-31M	$-21M	$-18M	$-23M
High	$-53M	$-51M	$-38M	$-35M	$-30M	$-20M	$-17M	$-22M
EPS Avg	$-1.08	$-1.04	$-0.79	$-0.71	$-0.62	$-0.41	$-0.35	$-0.45
Low	$-1.11	$-1.06	$-0.80	$-0.72	$-0.63	$-0.42	$-0.36	$-0.46
High	$-1.06	$-1.02	$-0.78	$-0.70	$-0.61	$-0.40	$-0.34	$-0.44
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Nov 14, 2025Stifel Nicolaus

DarioHealth Corp. (DRIO) PT Raised to $16 at Stifel Following 20-1 Stock Split

Target:$16.00

+50.8%from $10.61

Nov 16, 2022Industrial Alliance Securities

Alliance Global Partners Maintains Buy on DarioHealth, Lowers Price Target to $7.5

Target:$7.50

+44.8%from $5.18

Aug 18, 2022Cowen & Co.

Cowen & Co. Maintains Outperform on DarioHealth, Lowers Price Target to $14

Target:$14.00

+155.0%from $5.49

May 16, 2022Cowen & Co.

Cowen & Co. Maintains Outperform on DarioHealth, Raises Price Target to $18

Target:$18.00

+184.4%from $6.33

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance